Michael Minogue holds a dominant position in the Massachusetts Republican primary for governor ahead of the September 1 vote, driven by his decisive win of the party endorsement at the state convention, substantial self-funding from his career as former Abiomed CEO, and recent polling that shows him far ahead of rivals Brian Shortsleeve and Mike Kennealy. Shortsleeve brings experience from the Baker administration and MBTA leadership, while Kennealy, who held an early polling edge, withdrew after the convention and endorsed Minogue. Trader consensus reflects Minogue's organizational advantages and limited remaining campaign window, though late developments such as unexpected turnout shifts or new endorsements could still influence final primary results.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedMichael Minogue 98.0%
Brian Shortsleeve 2.2%
Mike Kennealy <1%
$29,474 Vol.
$29,474 Vol.

Michael Minogue
98%

Brian Shortsleeve
2%

Mike Kennealy
<1%
Michael Minogue 98.0%
Brian Shortsleeve 2.2%
Mike Kennealy <1%
$29,474 Vol.
$29,474 Vol.

Michael Minogue
98%

Brian Shortsleeve
2%

Mike Kennealy
<1%
If no 2026 Massachusetts Gubernatorial Republican Primary takes place, this market will resolve to “Other.”
The resolution source for this market will be the first official announcement of the results from the Massachusetts Republican Party; however, an overwhelming consensus of credible reporting may suffice.
Market Opened: Dec 10, 2025, 4:20 PM ET
Resolver
0x2F5e3684c...If no 2026 Massachusetts Gubernatorial Republican Primary takes place, this market will resolve to “Other.”
The resolution source for this market will be the first official announcement of the results from the Massachusetts Republican Party; however, an overwhelming consensus of credible reporting may suffice.
Resolver
0x2F5e3684c...Michael Minogue holds a dominant position in the Massachusetts Republican primary for governor ahead of the September 1 vote, driven by his decisive win of the party endorsement at the state convention, substantial self-funding from his career as former Abiomed CEO, and recent polling that shows him far ahead of rivals Brian Shortsleeve and Mike Kennealy. Shortsleeve brings experience from the Baker administration and MBTA leadership, while Kennealy, who held an early polling edge, withdrew after the convention and endorsed Minogue. Trader consensus reflects Minogue's organizational advantages and limited remaining campaign window, though late developments such as unexpected turnout shifts or new endorsements could still influence final primary results.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions